Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6195)
  2. Meeting Abstract (6166)
  3. Review (401)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (160)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11094)
  2. Hematologic Malignancies, Division of (10645)
  3. GSK Faculty (5449)
  4. Adult Leukemia (3723)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (946)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (317)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (268)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1669)
  3. Nature Publishing Group (1118)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SRSF2 mutations impair hematopoietic differentiation by altering exonic splicing enhancer preference
    Meeting Abstract

    Kim, E.; Ilagan, J. O.; Lee, S.; Ramakrishnan, A.; Chung, Y. R.; Micol, J. B.; Murphy, M. E.; Kim, M. K.; Zebari, A. S.; Feala, J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Photopheresis as part of conditioning reduces incidence of severe graft versus host disease: Fourteen year follow-up of a novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Kaul, E.; Shah, G. L.; Rosenberg, A. S.; Comenzo, R. L.; Smith, H.; Evens, A. M.; Cossor, F. I.; Kao, G. S.; Miller, K. B.; Klein, A. K.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Phase I trial of targeted alpha-particle therapy using actinium-225 (Ac-225)-lintuzumab (anti-CD33) in combination with low-dose cytarabine (LDAC) for older patients with untreated acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Smith, B. D.; Douer, D.; Estey, E. H.; Kantarjian, H. M.; Wahl, R. L.; Earle, D.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • AML genotype-specific and non-specific regulation of mesenchymal stromal cell transcriptome in the bone marrow microenvironment
    Meeting Abstract

    Jacamo, R.; Ling, X. Y.; Wang, Z. Q.; Ma, W. C.; Zhang, M.; Ruvolo, P. P.; Ruvolo, V. R.; Lowe, S. W.; Zuber, J.; Konopleva, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genomic profiling combining DNA and RNA analysis of 112 formalin-fixed paraffin-embedded diffuse large B cell lymphoma specimens identifies a high frequency of clinically relevant genomic alterations
    Meeting Abstract

    Intlekofer, A. M.; Hilden, P.; Seshan, V. E.; Copeland, A. R.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Leukemia-associated oncometabolite 2-hydroxyglutarate regulates epigenetic modifications in response to oxygen availability in cells without IDH1/2 mutations
    Meeting Abstract

    Intlekofer, A. M.; DeMatteo, R. G.; Finley, L. W.; Cross, J. R.; Thompson, C. B.
    Blood (2014)

    Fulltext@MSK | Save
  • SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS
    Meeting Abstract

    Inoue, D.; Matsui, H.; Hou, H. A.; Chou, W. C.; Nagamachi, A.; Kitaura, J.; Kawabata, K. C.; Togami, K.; Nagase, R.; Horikawa, S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders
    Meeting Abstract

    Hyman, D. M.; Diamond, E.; Vibat, C. R.; Hassaine, L.; Poole, J.; Patel, M.; Holley, V.; Cabrilo, G.; Lu, T. T.; Arcila, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • The efficacy of vemurafenib in Erdheim-Chester disease and Langerhans cell histiocytosis: Preliminary results from VE-basket study
    Meeting Abstract

    Hyman, D. M.; Diamond, E.; Subbiah, V.; Blay, J. Y.; Lockhart, A. C.; Abdel-Wahab, O.; SirzeĢn, F.; Veronese, M. L.; Laserre, S. F.; Elez, E.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Risk of arterial and venous thrombosis in 11,155 patients with myeloproliferative neoplasms and 44,620 matched controls; a population-based study
    Meeting Abstract

    Hultcrantz, M.; Andersson, T. M. L.; Landgren, O.; Derolf, A. R.; Dickman, P. W.; Bjorkholm, M.; Kristinsson, S. Y.
    Blood (2014)

    Fulltext@MSK | Save